Sat Medicine Traders Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 5.00 M
as on 18-07-2024
- Revenue -66.91%
(FY 2021)
- Profit -39.67%
(FY 2021)
- Ebitda -75.93%
(FY 2021)
- Net Worth 2.63%
(FY 2021)
- Total Assets -10.05%
(FY 2021)
About Sat Medicine Traders
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vandana Sood, Sumedha Sharma, Satish Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397PB2014PTC038507
- Company No.
038507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2014
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Hoshiarpur, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sat Medicine Traders?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Kumar  | Director | 18-Apr-2016 | Current |
| Vandana Sood | Director | 19-Mar-2014 | Current |
| Sumedha Sharma | Director | 18-Apr-2016 | Current |
| Anuj Sood | Director | 19-Mar-2014 | Current |
Financial Performance of Sat Medicine Traders.
Sat Medicine Traders Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 66.91% decrease. The company also saw a substantial fall in profitability, with a 39.67% decrease in profit. The company's net worth moved up by a moderate rise of 2.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sat Medicine Traders?
In 2021, Sat Medicine Traders had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sood Medicine Traders Private LimitedActive 35 years 9 monthsVandana Sood and Anuj Sood are mutual person
- Axon Health Care Private LimitedActive 24 years 7 months
Vandana Sood and Anuj Sood are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 25 Mar 2015 | ₹5.00 M | Satisfied |
How Many Employees Work at Sat Medicine Traders?
Unlock and access historical data on people associated with Sat Medicine Traders, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sat Medicine Traders, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sat Medicine Traders's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
